Lantheus to Present at Upcoming Investor Conferences
Rhea-AI Summary
Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, has announced its participation in three major upcoming investor conferences in February and March 2025. The company's management team will present at:
- B. Riley Securities Precision Oncology & Radiopharma Day in New York (February 28)
- TD Cowen 45th Annual Health Care Conference in Boston (March 4, 2:30 PM ET)
- Leerink Global Healthcare Conference 2025 in Miami (March 11, 1:40 PM ET)
Live webcasts will be available for the TD Cowen and Leerink conferences through the Investors section of Lantheus's website. Replay access will be maintained for at least 30 days following the presentations.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, LNTH declined 3.23%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
BEDFORD, Mass., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced members of its management team will present at the following upcoming investor conferences.
- B. Riley Securities Precision Oncology & Radiopharma Day in New York on February 28
- TD Cowen 45th Annual Health Care Conference in Boston on March 4 at 2:30 pm ET
- Leerink Global Healthcare Conference 2025 in Miami on March 11 at 1:40 pm ET
A live webcast will be available for the TD Cowen 45th Annual Health Care Conference and Leerink Global Healthcare Conference presentations on the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentations.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Senior Director, External Communications
646-975-2533
media@lantheus.com
FAQ
When is Lantheus (LNTH) presenting at the TD Cowen Healthcare Conference in 2025?
Which investor conferences is Lantheus (LNTH) attending in February and March 2025?
How long will Lantheus (LNTH) conference webcasts be available for replay?
Which of Lantheus's (LNTH) 2025 conference presentations will have live webcasts?
